Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ham

Showing results (221-230 of 225) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 225 results.
Journal of Alzheimer'S Disease : JAD|February 25, 2026
The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's diseaseAbigail G Nixon, Nancy S Hong, Behroo Mirza Agha, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Critical Care (London, England)|April 18, 2024
ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shockDaniel E Leisman, Damian R Handisides, Laurence W Busse, et al.
Annals of Intensive Care|December 16, 2023
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockDaniel E Leisman, Damian R Handisides, Lakhmir S Chawla, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Pageof 23

Showing results (221-230 of 225) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 225 results.
Journal of Alzheimer'S Disease : JAD|February 25, 2026
The effects of chronic cannabidiol administration on brain pathology and behavioral deficits found in the tau P301s-line PS19 mouse model of Alzheimer's diseaseAbigail G Nixon, Nancy S Hong, Behroo Mirza Agha, et al.
American Journal of Respiratory and Critical Care Medicine|July 2, 2020
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical TrialRinaldo Bellomo, Lui G Forni, Laurence W Busse, et al.
Critical Care (London, England)|April 18, 2024
ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shockDaniel E Leisman, Damian R Handisides, Laurence W Busse, et al.
Annals of Intensive Care|December 16, 2023
Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shockDaniel E Leisman, Damian R Handisides, Lakhmir S Chawla, et al.
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
Pageof 23